Development of DNA aptamers targeting low-molecular-weight amyloid-β peptide aggregatesin vitro
Chemical Communications2018Vol. 54(36), pp. 4593–4596
Citations Over TimeTop 13% of 2018 papers
Madhuri Chakravarthy, Hadi AlShamaileh, He Huang, R. K. Tannenberg, Suxiang Chen, Simon Worrall, Peter R. Dodd, Rakesh N. Veedu
Abstract
We have developed a novel functional nucleic acid aptamer to amyloid-β peptide 1-40 (Aβ1-40) and investigated its potential to detect Aβ peptide fragments in neuropathologically confirmed Alzheimer brain hippocampus tissues samples. Our results demonstrate that the aptamer candidate RNV95 could detect tetrameric/pentameric low-molecular-weight Aβ aggregates in autopsy hippocampal tissue from two neuropathologically confirmed Alzheimer disease cases. Although these are preliminary observations, detailed investigations are under way. This is the first demonstration of aptamer-Aβ binding in Alzheimer brain tissues.
Related Papers
- → Improved Nucleic Acid Triggered Probe Activation through the Use of a 5-Thiomethyluracil Peptide Nucleic Acid Building Block(2005)46 cited
- → Fibrillar and Oligomeric β‐Amyloid as Distinct Local Biomarkers for Alzheimer's Disease(2007)22 cited
- → Enhancing Peptide Nucleic Acid–Nanomaterial Interaction and Performance Improvement of Peptide Nucleic Acid-Based Nucleic Acid Detection by Using Electrostatic Effects(2022)6 cited
- → Pitfalls in the quantitative estimation of β-amyloid immunoreactivity in human brain tissue(1998)15 cited
- → Improved force fields for the simulations of structural and thermal dynamics of peptide nucleic acid (PNA) complexes with natural nucleic acids(2020)